Results 101 to 110 of about 494,085 (317)

Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab [PDF]

, 2013
<p>Objective To determine serum biomarker associations with clinical response to golimumab treatment in patients with psoriatic arthritis (PsA).</p> <p>Methods GO–REVEAL was a randomised, placebo-controlled study of golimumab in ...
Beutler, A., Elashoff, M., Gladman, D., Gomez-Reino, J.J., Kavanaugh, A., Krueger, G.G., Mack, M., McInnes, I.B., Mease, P.J., Murphy, F.T., Papp, K., Visvanathan, S., Wagner, C.L.   +12 more
core   +1 more source

Efficacy and Tolerability of Brodalumab in 42 Adult Patients With Moderate to Severe Psoriasis: First French Real‐Life Case Series on Hard‐to‐Treat Areas

JEADV Clinical Practice, EarlyView.
In our real‐life study, brodalumab demonstrates clinical efficacy on psoriasis lesions over a median duration of treatment of 4 months, associated with mean reductions of 94.3% for BSA, 93.1% for PASI and 88.0% for PGA. 23 patients no longer had a single lesion at the follow‐up visit.
Marc Perrussel, Bruno Sassolas
wiley   +1 more source

Peripheral γδ T Cells Regulate Neutrophil Expansion and Recruitment in Experimental Psoriatic Arthritis

Arthritis & Rheumatology, 2022
C. Nguyen, H. Furuya, D. Das, A. Marusina, A. Merleev, R. Ravindran, Z. Jalali, I. Khan, E. Maverakis, I. Adamopoulos   +9 more
semanticscholar   +1 more source

Epidemiology of psoriatic arthritis

Reumatismo, 2012
Epidemiological studies on psoriatic arthritis have long been hampered by the absence of widely accepted classification criteria. The development of the CASPAR (ClASsification criteria for Psoriatic ARthritis) criteria has recently provided the framework for conducting epidemiological studies in psoriatic arthritis using uniform recruitment criteria ...
Catanoso, M, Pipitone, N, SALVARANI, CARLO   +2 more
openaire   +5 more sources

The Impact of Methotrexate on Cardiovascular Outcomes in Psoriasis: A Systematic Review and Meta‐Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Psoriasis is a chronic immune‐mediated inflammatory disease with a global prevalence of 2%–3% and 1.3% in Brazil. It is associated with comorbidities such as obesity, hypertension, and diabetes, all of which contribute to increased cardiovascular risk due to systemic inflammation and endothelial dysfunction.
Tiago A. S. Costa, Sheila T. K. Medorima, Renata F. Magalhães   +2 more
wiley   +1 more source

Use of biological drugs in patients with psoriasis and psoriatic arthritis in italy: Results from the PSONG survey [PDF]

, 2018
This Italian multicenter retrospective study compared the drug survival and efficacy of differentanti-TNF agents in psoriasis (PsO) and psoriatic arthritis (PsA) patients.
Berardesca, E, Bernardini, N, Bianchi, L, Chimenti, S, Costanzo, A., D'Epiro, S, De Simone, C, Narcisi, A, Orsini, D, Peris, K, Potenza, Mc, Richetta, A, Teoli, M, Zangrilli, A   +13 more
core  

99mTc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients : a biodistribution and dosimetry study [PDF]

, 2016
Background: Biologicals directed against tumour necrosis factor (TNF) have proven their efficacy in the treatment of spondyloarthritis and rheumatoid arthritis.
Bacher, Klaus, Beyaert, Rudi, Carron, Philippe, D'Asseler, Yves, De Vos, Filip, Dumolyn, Caroline, Elewaut, Dirk, Lambert, Bieke, Van den Bosch, Filip, Verbruggen, August   +9 more
core   +2 more sources

Radiological changes in the sacro-iliac joints and spine of patients with psoriatic arthritis and psoriasis. [PDF]

, 1968
I Jajić
openalex   +1 more source

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial

Arthritis & Rheumatology, 2019
To examine the efficacy of methotrexate monotherapy relative to etanercept monotherapy and the value of combining methotrexate and etanercept for the treatment of patients with psoriatic arthritis (PsA).
P. Mease, D. Gladman, D. Collier, C. Ritchlin, P. Helliwell, L. Liu, G. Kricorian, J. Chung   +7 more
semanticscholar   +1 more source

Successful Treatment of Spesolimab in a Haemodialysis Patient With Acutely Flaring Generalised Pustular Psoriasis

JEADV Clinical Practice, EarlyView.
Capsule Summary Generalised pustular psoriasis is one of the severe dermatological disorders. The use of biologics in psoriatic patients with end‐stage renal disease is rare, and the safety information on biologics treatment in such patients is limited.
Yasuyuki Fujita, Sota Itamoto, Akihiro Orita, Kunihiro Kawashima, Satoko Shimizu   +4 more
wiley   +1 more source